Africa Western and Central | Immunization, measles (% of children ages 12-23 months)
Child immunization, measles, measures the percentage of children ages 12-23 months who received the measles vaccination before 12 months or at any time before the survey. A child is considered adequately immunized against measles after receiving one dose of vaccine. Development relevance: Immunization is one of the most cost-effective public health interventions, and ??is an essential component for reducing under-five mortality. Immunization coverage estimates are used to monitor coverage of immunization services and to guide disease eradication and elimination efforts. Limitations and exceptions: In many developing countries a lack of precise information on the size of the cohort of one-year-old children makes immunization coverage difficult to estimate from program statistics. Statistical concept and methodology: Governments in developing countries usually finance immunization against measles and diphtheria, pertussis (whooping cough), and tetanus (DTP) as part of the basic public health package. The data shown here are based on an assessment of national immunization coverage rates by the WHO and UNICEF. The assessment considered both administrative data from service providers and household survey data on children's immunization histories. Based on the data available, consideration of potential biases, and contributions of local experts, the most likely true level of immunization coverage was determined for each year. Notes on regional and global aggregates: When the vaccine is not introduced in a national immunization schedule, the missing value is assumed zero (or close to zero) in the relevant groups' averages.
Publisher
The World Bank
Origin
Africa Western and Central
Records
63
Source
Africa Western and Central | Immunization, measles (% of children ages 12-23 months)
1960
1961
1962
1963
1964
1965
1966
1967
1968
1969
1970
1971
1972
1973
1974
1975
1976
1977
1978
1979
2.21335831 1980
5.30788329 1981
6.00982693 1982
5.84499484 1983
12.40516734 1984
21.4825439 1985
31.06692924 1986
35.90876255 1987
42.50064785 1988
51.95336468 1989
52.89060866 1990
52.74490368 1991
44.86959629 1992
43.34664259 1993
44.58706977 1994
48.14245504 1995
44.87568085 1996
44.89000263 1997
43.73817927 1998
44.40773461 1999
44.60798582 2000
44.60071273 2001
44.83469348 2002
48.64242374 2003
51.13609795 2004
55.32608932 2005
57.49449169 2006
56.98367866 2007
62.24778542 2008
68.41093266 2009
65.42878191 2010
61.64170836 2011
60.47677041 2012
59.79865454 2013
59.1393375 2014
58.79737031 2015
61.46061109 2016
64.22396413 2017
64.71459409 2018
65.7517654 2019
65.44002821 2020
66.64636102 2021
65.78037582 2022
Africa Western and Central | Immunization, measles (% of children ages 12-23 months)
Child immunization, measles, measures the percentage of children ages 12-23 months who received the measles vaccination before 12 months or at any time before the survey. A child is considered adequately immunized against measles after receiving one dose of vaccine. Development relevance: Immunization is one of the most cost-effective public health interventions, and ??is an essential component for reducing under-five mortality. Immunization coverage estimates are used to monitor coverage of immunization services and to guide disease eradication and elimination efforts. Limitations and exceptions: In many developing countries a lack of precise information on the size of the cohort of one-year-old children makes immunization coverage difficult to estimate from program statistics. Statistical concept and methodology: Governments in developing countries usually finance immunization against measles and diphtheria, pertussis (whooping cough), and tetanus (DTP) as part of the basic public health package. The data shown here are based on an assessment of national immunization coverage rates by the WHO and UNICEF. The assessment considered both administrative data from service providers and household survey data on children's immunization histories. Based on the data available, consideration of potential biases, and contributions of local experts, the most likely true level of immunization coverage was determined for each year. Notes on regional and global aggregates: When the vaccine is not introduced in a national immunization schedule, the missing value is assumed zero (or close to zero) in the relevant groups' averages.
Publisher
The World Bank
Origin
Africa Western and Central
Records
63
Source